Navigation Links
Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate
Date:12/16/2008

SAN MARINO, Calif., Dec. 16 /PRNewswire/ -- Epeius Biotechnologies Corporation, a leader in tumor-targeted gene delivery systems, has received two additional European patents for the platform targeting technologies and molecular designs that enable precision gene delivery to primary cancers and metastatic lesions that have spread throughout the body. With profound demonstrations of clinical benefit and single-agent-efficacy, as well as overall safety, Epeius Biotech continues to lead the field of clinical gene medicine with the advent of pathotropic (or disease-seeking) targeting. These latest EU patents follow on the heels of a major clinical patent that was recently awarded in the USA for targeted gene delivery in vivo. Together these clinical patents provide additional intellectual property protection for the platform of highly advanced biotechnologies embodied in the company's leading anti-cancer agent Rexin-G(R) -- the first and so far only tumor-targeted gene delivery system that has been successfully validated in the clinic.

Based on recent breakthroughs in tumor-targeting and nanotechnology, a new generation of powerful biological anti-cancer agents that are exceedingly precise and highly selective for diseased tissues is currently in clinical development. Anti-cancer agents such as Rexin-G(R) can be delivered by simple intravenous infusion, yet are programmed to seek-out and accumulate selectively in primary and metastatic lesions that have spread throughout the body, delivering a tumor-killing gene while sparing normal cells and tissues. Representing the world's first targeted genetic medicine proven to be both safe and effective in the clinic, Rexin-G(R) is commercially available in the Philippines -- for use in all solid tumors that are refractory to standard chemotherapy -- and is currently in clinical trials in the USA for several types of cancer.

About Epeius Biotechnologies

Epei
'/>"/>

SOURCE Epeius Biotechnologies
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Targeting Metastatic Cancer From the Inside: Epeius Biotech Reveals a New Generation of Tools for Medical Gene Delivery
2. Epeius Biotechnologies Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal
3. FDA Grants Epeius Biotechnologies Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
4. Epeius Biotechnologies Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma
5. Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
6. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
7. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
8. Oncolytics Biotech Inc.s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study
9. Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc.
10. Axial Biotech Launches Genetic Test for Adolescent Idiopathic Scoliosis (AIS)
11. Investor Group Reconfigures Proposed Slate of Replacement Directors for Trinity Biotech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014  Orexigen Therapeutics, Inc. (Nasdaq: OREX ... List of Outstanding Issues (LOI) from the European Medicines ... for the NB32 Marketing Authorization Application (MAA). NB32 (naltrexone ... drug candidate being evaluated for weight loss. ... point were adequately addressed by the Company based in ...
(Date:7/30/2014)...  AtheroNova Inc. (OTCBB: AHRO), a biotech company ... to safely regress atherosclerotic plaque and improve lipid ... CardioNova, has accomplished first dosing of subjects for ... compound, AHRO-001.  This Phase 1b trial will be ... trial completed in February 2014, in which patients ...
(Date:7/30/2014)... July 30, 2014 Vala Sciences ... U.S. Environmental Protection Agency (EPA). This new contract ... toxicity models, including tests designed to assess the ... the formation of connections between neurons (synapses), which ... and synapse formation by environmental pollutants likely contributes ...
(Date:7/29/2014)... MA (PRWEB) July 30, 2014 ... (UC) and collaboration company, is proud to announce ... account management positions in their Boston, Charleston and ... response to the increased demand for hosted solutions, ... operational efficiency and reduce cost. , SoundConnect was ...
Breaking Biology Technology:Orexigen Receives CHMP Day 180 List of Outstanding Issues 2Orexigen Receives CHMP Day 180 List of Outstanding Issues 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 2AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 4U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 2U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 3SoundConnect Organization and Culture is Evolving 2
... Consulting announced that it has appointed A.J. Whalen as Solutions ... ... September 8, 2008 -- www.symphony-consulting.com [Symphony Management Consulting] ... , , , ,Mr. Whalen joins Symphony from Wellesley Information ...
... Cell Therapeutics, Inc.,(CTI) (Nasdaq: CTICD ; ... a letter from the Listing Qualifications Staff of ... is not in compliance with the,$50,000,000 minimum market ... Marketplace Rule 4450(b)(1)(A). Furthermore, the Company does not,comply ...
... should have so much patience to solder nanowires to ... billionth of a meter.) , That,s why a new ... many prepatterned electrodes was selected for a 2008 Nano ... many difficulties. , "All of the electroplating is done ...
Cached Biology Technology:Symphony Managemnt Consulting Hires New Solutions Director 2CTI Receives NASDAQ Letter 2CTI Receives NASDAQ Letter 3Parallel 'nano-soldering' technique chosen for year's top-50 by Nanotech Briefs 2
(Date:7/29/2014)... and sea ice retreats, the North is changing. An ... water which is predicted to extend across the whole ... thus have the potential to create Arctic swell ... element to the region. , A University of Washington researcher ... of the Arctic Ocean, and detected house-sized waves during ...
(Date:7/29/2014)... at a restaurant, don,t blame yourself; blame the menu. ... you want and more to do with a menu,s layout ... of over 300 diners, the Cornell study published this month ... that when it comes to what you order for dinner, ... and how you imagine it will taste. , First, any ...
(Date:7/29/2014)... role in locomotion. Swimming microorganisms, such as bacteria and ... to the viscous forces exerted by the surrounding fluid. ... Now, scientists have found that the direction of propulsion ... induced by a viscoelastic fluid. These findings have been ... from the Alternative Energies and Atomic Energy Commission (CEA), ...
Breaking Biology News(10 mins):Huge waves measured for first time in Arctic Ocean 2Huge waves measured for first time in Arctic Ocean 3Menu secrets that can make you slim by design 2Optimum inertial self-propulsion design for snowman-like nanorobot 2
... in aquatic sediments and soils can contaminate local food ... be expensive and destructive. Researchers from the Smithsonian Environmental ... found a new low-cost, nonhazardous way to reduce the ... the soil. Mercury-contaminated "Superfund sites" contain some ...
... variants may help explain the response of patients with ... to a meta-analysis reported today (Oct. 25) at the ... The meta-analysis used statistical methods to combine results ... Caucasian patients with moderate to severe COPD. Over ...
... By tuning gold nanoparticles to just the right size, researchers ... carbon dioxide (CO 2 ) to carbon monoxide (CO), an ... fuels and commodity chemicals. "Our study shows potential of ... useful forms of carbon," said Shouheng Sun, professor of chemistry ...
Cached Biology News:New low-cost, nondestructive technology cuts risk from mercury hot spots 2DNA variants may influence COPD patients' response to inhaled bronchodilators 2Gold nanoparticles give an edge in recycling CO2 2
... an inert polymer with a unique split septum ... septum caps for use with 384-well tall-chimney plates ... used in conjunction with screw or clip-down hot ... equipment 384 septum caps may be pierced ...
... . The sensitive conductivity detector CE 4710, ... the measuring cell in a thermostatted environment. ... Data processing is provided by the CE 4900 ... high pressure CE 4100 dual piston pump. ...
Sufficient reagents for 50 applications.Mitochondria Isolation Kit Reagent A, 50 ml Mitochondria Isolation Kit Reagent B, 500 l Mitochondria Isolation Kit Reagent C, 70 ml...
... is designed to allow ampicillin selection in ... driving the gene for ampicillin resistance is ... promoter. It mediates higher transcription efficiency than ... polyadenylation signal terminates the ampicillin expression. The ...
Biology Products: